Prognostic impact of rapid involved light chain reduction in first line therapy with Bendamustine, Prednisone and Bortezomib (BPV) in myeloma patients

2019 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []